PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

NCT03983876 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Phase 1

Interventions

DRUG: Adalimumab

Sponsor

Alvotech Swiss AG